Nothing Is Undruggable: Novartis' Bradner On CAR-T, CRISPR & DNA Libraries

 
• By Sten Stovall
  
James Bradner, President of the Novartis Institutes for BioMedical Research (NIBR)
James Bradner, President, Novartis Institutes for BioMedical Research (NIBR) • Source: Novartis AG

More from R&D

More from Scrip